Aisling Capital Management LP

Aisling Capital Management LP latest Q4_2020 13F filings reported $586,477,000 in market value on this 2021-02-04 report date . The portfolio quarterly return is 87.35%. This fund has 16 securities concentrations of 100% weights.

Aisling Capital Management LP largest holding is BridgeBio Pharma Inc. with weight of 48.72% and $283,687,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-042020-12-31Q4_202013F-HR16$586,477,00087.35%
2020-11-122020-09-30Q3_202013F-HR15$313,036,00019.46%
2020-08-102020-06-30Q2_202013F-HR13$262,045,00014.15%
2020-05-112020-03-31Q1_202013F-HR14$229,556,000-12.05%
2020-02-062019-12-31Q4_201913F-HR13$261,004,00036.06%
2019-11-132019-09-30Q3_201913F-HR13$191,825,000-18.07%
2019-08-132019-06-30Q2_201913F-HR/A14$234,139,0000.00%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
BRIDGEBIO PHARMA INCBBIOINCR$283,6870.90%48.72%$71.110.00%3,989,412
EIDOS THERAPEUTICS INCBBIOINCR$147,8471.60%25.39%$131.580.00%1,123,630
HARMONY BIOSCIENCES HLDGS INHRMYINCR$30,4680.07%5.23%$36.150.00%842,815
SPRUCE BIOSCIENCES INCSPRBBUY$29,3060.00%5.03%$24.310.00%1,205,511
SYNDAX PHARMACEUTICALS INCSNDXINCR$22,7960.51%3.91%$22.240.00%1,025,000
AVROBIO INCAVROINCR$14,0760.07%2.42%$13.940.00%1,009,779
AEGLEA BIOTHERAPEUTICS INCAGLEINCR$13,3090.11%2.29%$7.870.00%1,691,151
POSEIDA THERAPEUTICS INCPSTXINCR$11,4450.24%1.97%$10.970.00%1,043,267
VERONA PHARMA PLCVRNAINCR$9,3270.12%1.60%$7.000.00%1,332,485
ATRECA INCBCELINCR$6,2610.16%1.08%$16.150.00%387,653
ACLARIS THERAPEUTICS INCACRSBUY$4,1050.00%0.70%$6.470.00%634,455
MARKER THERAPEUTICS INCMRKRDECR$2,900-0.03%0.50%$1.450.00%2,000,000
OBSEVA SAOBSVDECR$2,884-0.16%0.50%$2.080.00%1,386,338
SUNESIS PHARMACEUTICALS INCSNSSINCR$2,0100.59%0.35%$1.990.00%1,010,000
ZOSANO PHARMA CORPZSANDECR$1,433-0.67%0.25%$0.530.00%2,718,226
NABRIVA THERAPEUTICS PLCDECR$462-0.55%0.08%$2.42-0.90%191,028